Swiss drug developer Relief Therapeutics upsizes proposed offering to $25M

Dec. 23, 2022 4:52 PM ETRelief Therapeutics Holding AG (RLFTF)By: Val Kennedy, SA News Editor3 Comments

Blue IPO background

Andrey Tolkachev

Swiss biopharma Relief Therapeutics (RLFT) (OTCQB:RLFTF) (RLFTD) has disclosed terms for an upsized $25M offering and Nasdaq uplisting.

The drug developer said in a filing that it is looking at offering 4.2M units priced between $5.50 and $6.50, which would

Recommended For You

Comments (3)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.